Cover Image




Von Willebrand disease is the most common  inherited bleeding disorder, found in approximately 1 of the general population ,without ethnic differences(1,2).VWD is the result of a deficiency or defect in Von Willebrand factor ,the large multimeric protein which mediates platelet adhesion and serves as a carrier protein for factor VIII. There are three major types. Type 1 is the result of a partial ,quantitative  deficiency of a structurally normal VWF, and accounts for   70-80 of all VWD patients. Type 2 includes several qualitative defects in VWF that affects its multimeric structure or function. Patients with type3 VWD are homozygous or doubly  heterozygous for two mutant VWF alleles ,with a resulting complete deficiency of VWF and a secondary severe   deficiency of FVIII. Although the autosomal inheritance  pattern predicts that both sexes should be equally affected, there is a higher frequency of symptomatic VWD in women because of the haemostatic challenges of menses, pregnancy and delivery(3-5). Pregnancy in these women requires          specialised and individualised management provided by a multidisciplinary team of obstetricians, haematologists and anaesthetists.


Full Text:



Rodeghiero F, Castaman G, Dini E.Epidemiological investigation of the prevalence of Von Willebrand’s disease.Blood 1987;69:454-9.

Werner EJ,Broxson EH,Tucker EL,Giroux DS,ShultsJ ,Abshire TC.Prevalence of Von Willebrand’s disease in children:a multiethnic study.J Pediatr1993;123:893-8.

Sadler JE,Mannucci PM,Berntorp E,Bochkov N,Boulyjenkov V,Ginsburg D,Meyer D,Peake I,Rodeghiero F,Srivastava A.Impact ,diagnosis and treatment of Von Willebrand’s disease. Thromb Haemost 2000;84:160-74.

Silwer J.Von Willebrand’s disease in Sweden.Acta Paediatr Scand Suppl 1973;238;1-159.

Miller CH,Graham JB,Goldin LR,Elston RC.Genetics of classic Von Willebrand’s disease.I.Phenotypic variation within families Blood 1979;54:117-36.

Sie P,Caron C,Azam J,Goudemand J,Grandjean H,Boneu B,Foumie A.Reassessment of Von Willebrand factor, VWF propeptide, factor VIII. C and plasminogen activator inhibitors 1 and 2 during normal pregnancy.Br J Haematol 2003;121:897-903.

Clark P,Brennand J,Conkie JA,McCall F,Greer IA,Walker ID.Activated protein C sensitivity,protein C,protein S and coagulation in normal pregnancy.Thromb Haemost 1998;79:1166-70.

Strauss HS,Diamond LK.Elevation of factor viii during pregnancy in normal persons and in a patient with Von Willebrand’s disease.N Engl J Med 1963;269:1251-2.

Sanchez-Luceros A, Meschengieser SS,Marchese C,Votta R, Casais P, Woods AI, Nadal MV, Salviu MJ,Lazzari MA.Factor VIII and Von Willebrand factor changes during normal pregnancy and puerperium.Blood Coagul Fibrinolysis 2003;14:647-51.

Hanna W ,McCarroll D,McDonald T,Painter P,Tuller J,Chen J,Lange R. Variant Von Willebrand’s disease and pregnancy.Blood 1981;58:873-9.

Wickstrom K, Eldelstam G, Lowbeer CH, Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronectin, Von Willebrand factor, free protein S and antithrombin during third trimester pregnancy. Scand J Clin Lab Invest 2004;64:31-40.

Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984:52:176-82.

Nichols WL, Hultin MB,James AH,et al.Von Willebrand disease :evidence based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute Expert Panel report.Haemophilia 2008;14:171-232.

Ramsahoye BH, Davies SV, Dasani H, Rearson JF. Obstetric management in VonWillebrand’s disease: a report of 24 pregnancies and a review of literature.Hemophilia 1995;1:140-4.

Mannucci PM.Treatment of Von Willebrand’s disease.N Engl Med 2004;351:68-94


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University